– advertise –
The Management Board of the Community Council of Castilla-La Mancha has authorized the conclusion of a contract for the supply of calendar vaccines for the residents of Castilla-La Mancha in 2024 in the amount of 9,770,789.6 euros. The contract is divided into 16 batches, totaling 321,250 doses.
Vaccine procurement for next year includes:
- 45,000 doses of hexavalent vaccines against hepatitis B, diphtheria, tetanus, acellular pertussis, inactivated polio and Haemophilus influenzae type b conjugate.
- 24,000 doses of diphtheria, tetanus, acellular pertussis and inactivated polio vaccines.
- 250 doses of Haemophilus influenzae type B conjugate vaccine.
- 12,000 doses of diphtheria, tetanus, acellular pertussis vaccine with reduced antigen content.
- 26,000 doses of diphtheria and tetanus vaccine with reduced antigen content.
- $19,000 for childhood hepatitis B vaccine.
- Hepatitis B vaccine for adults 2,000 doses.
- 11,000 doses of hepatitis A vaccine for children.
- 3,500 doses of hepatitis A vaccine for adults.
- 6,000 doses of measles, rubella and mumps vaccine.
- 20,000 doses of chickenpox and other vaccines.
- 28,000 doses of measles, rubella, mumps and chickenpox vaccine.
- 18,000 doses of meningococcal C conjugate vaccine.
- 26,500 doses of vaccine against serogroup B meningococci.
- 45,000 doses of non-valent HPV vaccine.
- 35,000 doses of 23-valent pneumococcal polysaccharide vaccine. /
– advertise –